Literature DB >> 5668051

Spastic dysphonia. II. Comparison with essential (voice) tremor and other neurologic and psychogenic dysphonias.

A E Aronson, J R Brown, E M Litin, J S Pearson.   

Abstract

Entities:  

Mesh：

Year:  1968        PMID： 5668051     DOI： 10.1044/jshd.3303.219

Source DB:  PubMed          Journal:  J Speech Hear Disord        ISSN： 0022-4677


× No keyword cloud information.
  15 in total

Review 1.  Laryngospasm in neurological diseases.

Authors:  Hans-Jürgen Gdynia; Jan Kassubek; Anne-Dorte Sperfeld
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  Coprevalence of anxiety and depression with spasmodic dysphonia: a case-control study.

Authors:  Laura J White; Edie R Hapner; Adam M Klein; John M Delgaudio; John J Hanfelt; H A Jinnah; Michael M Johns
Journal:  J Voice       Date:  2011-12-29       Impact factor: 2.009

3.  Defining differences in patient characteristics between spasmodic dysphonia and laryngeal tremor.

Authors:  Priyesh N Patel; Edmond K Kabagambe; Jennifer C Starkweather; Matthew Keller; Zaki A Ahmed; Simone C Gruber; Jordan S Akins; C Gaelyn Garrett; David O Francis
Journal:  Laryngoscope       Date:  2018-11-13       Impact factor: 3.325

4.  [Functional disorders of the voice and their treatment (author's transl)].

Authors:  G Habermann
Journal:  Arch Otorhinolaryngol       Date:  1980

5.  Coprevalence of tremor with spasmodic dysphonia: a case-control study.

Authors:  Laura J White; Adam M Klein; Edie R Hapner; John M Delgaudio; John J Hanfelt; Hyder A Jinnah; Michael M Johns
Journal:  Laryngoscope       Date:  2011-08       Impact factor: 3.325

Review 6.  Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.

Authors:  A Berardelli; G Abbruzzese; L Bertolasi; G Cantarella; F Carella; A Currà; D De Grandis; G DeFazio; G Galardi; P Girlanda; P Livrea; N Modugno; A Priori; G Ruoppolo; L Vacca; M Manfredi
Journal:  Ital J Neurol Sci       Date:  1997-10

Review 7.  Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.

Authors:  Andrew Blitzer; Mitchell F Brin; Kristina Simonyan; Laurie J Ozelius; Steven J Frucht
Journal:  Laryngoscope       Date:  2017-12-08       Impact factor: 3.325

8.  Clinical aspects of spasmodic dysphonia.

Authors:  M J Aminoff; H H Dedo; K Izdebski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-04       Impact factor: 10.154

9.  A comparison of bilateral and unilateral botulinum toxin treatments for spasmodic dysphonia.

Authors:  P Zwirner; T Murry; G E Woodson
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 10.  Treatment for spasmodic dysphonia: limitations of current approaches.

Authors:  Christy L Ludlow
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2009-06       Impact factor: 1.814
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.